BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 29660832)

  • 21. Immunosuppressive therapy in patients with IgA nephropathy.
    Peters HP; van den Brand JA; Berger SP; Wetzels JF
    Neth J Med; 2015 Jul; 73(6):284-9. PubMed ID: 26228193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progression of IgA nephropathy under current therapy regimen in a Chinese population.
    Li X; Liu Y; Lv J; Shi S; Liu L; Chen Y; Zhang H
    Clin J Am Soc Nephrol; 2014 Mar; 9(3):484-9. PubMed ID: 24408121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma neutrophil gelatinase-associated lipocalin as a potential predictor of adverse renal outcomes in immunoglobulin A nephropathy.
    Park GY; Yu CH; Kim JS; Kang YJ; Kwon O; Choi JY; Cho JH; Kim CD; Kim YL; Park SH
    Korean J Intern Med; 2015 May; 30(3):345-53. PubMed ID: 25995665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.
    Peters HP; Waanders F; Meijer E; van den Brand J; Steenbergen EJ; van Goor H; Wetzels JF
    Nephrol Dial Transplant; 2011 Nov; 26(11):3581-8. PubMed ID: 21467131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
    Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
    Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implication of urinary complement factor H in the progression of immunoglobulin A nephropathy.
    Liu M; Chen Y; Zhou J; Liu Y; Wang F; Shi S; Zhao Y; Wang S; Liu L; Lv J; Zhang H; Zhao M
    PLoS One; 2015; 10(6):e0126812. PubMed ID: 26035554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of NGAL staining in patients with IgA nephropathy.
    Yavas H; Sahin OZ; Ersoy R; Taşlı F; Gibyeli Genek D; Uzum A; Cirit M
    Ren Fail; 2013; 35(4):472-6. PubMed ID: 23413884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy.
    Bazzi C; Rizza V; Casellato D; Stivali G; Rachele G; Napodano P; Olivieri G; Gallieni M; D'Amico G
    J Nephrol; 2012; 25(5):810-8. PubMed ID: 22252844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Independent or synergistic relationship of proteinuria and glomerular filtration rate on patient and renal survival in patients with glomerulonephritis?
    Haider DG; Masghati S; Goliasch G; Fuhrmann V; Soleiman A; Wolzt M; Baierl A; Druml W; Hörl WH
    J Nephrol; 2014 Dec; 27(6):643-51. PubMed ID: 24609889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and prognostic significance of C1q deposition in IgAN patients-a retrospective study.
    Tian S; Yang X; Luo J; Guo H
    Int Immunopharmacol; 2020 Nov; 88():106896. PubMed ID: 33182045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IgA nephropathy clinicopathologic study following the Oxford classification: Progression peculiarities and gender-related differences.
    Riispere Ž; Laurinavičius A; Kuudeberg A; Seppet E; Sepp K; Ilmoja M; Luman M; Kõlvald K; Auerbach A; Ots-Rosenberg M
    Medicina (Kaunas); 2016; 52(6):340-348. PubMed ID: 27932191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lower serum bilirubin is associated with poor renal outcome in IgA nephropathy patients.
    Jiang Z; Tan J; Wang S; Dong L; Han X; Tang Y; Qin W
    Int J Med Sci; 2021; 18(13):2964-2970. PubMed ID: 34220324
    [No Abstract]   [Full Text] [Related]  

  • 33. Tonsillectomy has beneficial effects on remission and progression of IgA nephropathy independent of steroid therapy.
    Maeda I; Hayashi T; Sato KK; Shibata MO; Hamada M; Kishida M; Kitabayashi C; Morikawa T; Okada N; Okumura M; Konishi M; Konishi Y; Endo G; Imanishi M
    Nephrol Dial Transplant; 2012 Jul; 27(7):2806-13. PubMed ID: 22492824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [IgA nephropathy - prognostic factors and treatment].
    Wieliczko M; Dylewska M
    Wiad Lek; 2016; 69(5):707-710. PubMed ID: 28033590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort.
    Coppo R; Lofaro D; Camilla RR; Bellur S; Cattran D; Cook HT; Roberts IS; Peruzzi L; Amore A; Emma F; Fuiano L; Berg U; Topaloglu R; Bilginer Y; Gesualdo L; Polci R; Mizerska-Wasiak M; Caliskan Y; Lundberg S; Cancarini G; Geddes C; Wetzels J; Wiecek A; Durlik M; Cusinato S; Rollino C; Maggio M; Praga M; K Smerud H; Tesar V; Maixnerova D; Barratt J; Papalia T; Bonofiglio R; Mazzucco G; Giannakakis C; Soderberg M; Orhan D; Di Palma AM; Maldyk J; Ozluk Y; Sudelin B; Tardanico R; Kipgen D; Steenbergen E; Karkoszka H; Perkowska-Ptasinska A; Ferrario F; Gutierrez E; Honsova E
    Pediatr Nephrol; 2017 Jan; 32(1):139-150. PubMed ID: 27557557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesangial C4d deposition: a new prognostic factor in IgA nephropathy.
    Espinosa M; Ortega R; Gómez-Carrasco JM; López-Rubio F; López-Andreu M; López-Oliva MO; Aljama P
    Nephrol Dial Transplant; 2009 Mar; 24(3):886-91. PubMed ID: 18842673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors for progression in immunoglobulin A nephropathy with significant proteinuria.
    Hwang HS; Kim BS; Shin YS; Yoon HE; Song JC; Choi BS; Park CW; Yang CW; Kim YS; Bang BK
    Nephrology (Carlton); 2010 Mar; 15(2):236-41. PubMed ID: 20470285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic relevance of clinical and histological features in IgA nephropathy treated with steroid and angiotensin receptor blockers.
    Choi S; Lee D; Jeong KH; Moon JY; Lee SH; Lee TW; Ihm CG
    Clin Nephrol; 2009 Nov; 72(5):353-9. PubMed ID: 19863877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Copeptin, a surrogate marker for arginine vasopressin, is associated with disease severity and progression in IgA nephropathy patients.
    Zittema D; van den Brand JA; Bakker SJ; Wetzels JF; Gansevoort RT
    Nephrol Dial Transplant; 2017 Jan; 32(suppl_1):i146-i153. PubMed ID: 28057871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and prognostic implications of serum uric acid levels on IgA nephropathy: a cohort study of 348 cases with a mean 5-year follow-up.
    Cheng GY; Liu DW; Zhang N; Tang L; Zhao ZZ; Liu ZS
    Clin Nephrol; 2013 Jul; 80(1):40-6. PubMed ID: 23391320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.